Clinical Trials Browser

human papillomavirus vaccine, L1 type 16, 18 × 30 days × Clear all

NCT05237947 2026-03-19

PRISMA

Phase 4 Active not recruiting

Human Papillomavirus-Related Cervical Carcinoma